The COVID-19 pandemic significantly reduced the number of sexual partners and sexual encounters in the U.S., with non-married women experiencing the most pronounced declines.
Nouscom extends Series C round to $82m for cancer vaccine trials – Pharmaceutical Technology
Share this article Switzerland-based Nouscom will use the funds to advance and expand its cancer vaccine clinical pipeline. Image credit: Shutterstock/eamesBot. Immuno-oncology company Nouscom has